Defence Research and Development Organisation (DRDO) on Tuesday released guidelines on how and when to use its anti-Covid medicine 2-Deoxy-d-glucose (2-DG) medicine. The drug was launched last month by the Ministry of Defence. It has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of the DRDO, in collaboration with Dr Reddy’s Laboratories (DRL) in Hyderabad.
The DRDO said that 2-DG medicine should be used under the supervision of a doctor. The oral drug for emergency use is an adjunct therapy to treat severe Covid patients. It reduces dependence on supplemental oxygen.
The drug was cleared by Drugs Controller General of India (DCGI) on May 1 for emergency use as an adjunct therapy in moderate to severe Covid-19 patients. The first batch of the indigenously developed anti-Covid-19 drug was released by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan on May 17.
The price of DRDO’s 2DG anti-COVID 19 drug has been fixed at Rs 990 per sachet by pharma major Dr Reddy’s Laboratories. However, the drug will be provided by government hospitals at a discounted price. According to Dr Reddy’s Laboratories, the drug will be commercially launched in mid-June.
Bread is one of the most consumed foods worldwide, present in nearly every culture and…
Bread is one of the most consumed foods worldwide, present in nearly every culture and…
Nutritional deficiency poses a significant threat to the health and well-being of the elderly, leading…
Scared to Travel Because of Diabetes? Follow These Dos and Don’ts for a Hassle-Free Trip…
Anger issues:Being angry is harmful for health. Sometimes in anger we take such steps which…
5 Things Your Body Can't Do Without Vitamin D: The Importance of This Essential Nutrient…